Skip to main content
Erschienen in: Journal of Nuclear Cardiology 6/2023

12.05.2023 | ORIGINAL ARTICLE

Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for “clean blood pool” imaging

verfasst von: Christopher L. Hansen, MD, MASNC

Erschienen in: Journal of Nuclear Cardiology | Ausgabe 6/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Myocardial imaging with bone agents such as Tc-99 m PYP and HMDP has assumed a central role in the evaluation of patients with suspected transthyretin (TTR) amyloidosis. Visual scoring (VS) (0–3 +) and the heart to contralateral lung ratio (HCL) classify many patients as equivocal when mediastinal uptake is apparent but cannot be further differentiated into myocardial uptake versus blood pool. SPECT imaging has been recommended but current reconstruction protocols frequently produce amorphous mediastinal activity that also fails to discriminate between myocardial activity and blood pool. We hypothesized that interactive filtering interactively using a deconvolving filter would improve this.

Methods

We identified 176 sequential patients referred for TTR amyloid imaging. All patients had planar imaging, 101 had planar imaging with a large field of view camera that allowed HCL measurements. SPECT imaging was performed on a 3-headed digital camera with lead fluorescence attenuation correction. One study was excluded for technical reasons. We created software to allow interactive filtering while reconstructing the images then overlay them on attenuation mu maps to assist localization of myocardial/mediastinal uptake. Conventional Butterworth and an interactive inverse Gaussian filters were employed to differentiate myocardial uptake from residual blood pool. We defined “clean blood pool” (CBP) as recognizable blood pool with no activity in the surrounding myocardium. A scan was determined diagnostic if it showed CBP, positive uptake or no identifiable mediastinal uptake.

Results

76/175 (43%) were equivocal (1 +) by visual uptake. Of these 22 (29%) were diagnostic by Butterworth but 71 (93%) were by inverse gaussian (p < .0001). 71/101 (70%) were equivocal by HCL (1–1.5). Of these, 25 (35%) were diagnostic by Butterworth but 68 (96%) were diagnostic by inverse gaussian (p < .0001). This was driven by a greater than threefold increase in the identification of CBP by inverse gaussian filtering.

Conclusion

CBP can be identified in the vast majority of patients with equivocal PYP scans using optimized reconstruction and can greatly reduce the number of equivocal scans.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Gertz MA, Brown ML, Hauser MF, Kyle RA. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Arch Intern Med 1987;147:1039‐44.CrossRefPubMed Gertz MA, Brown ML, Hauser MF, Kyle RA. Utility of technetium Tc 99m pyrophosphate bone scanning in cardiac amyloidosis. Arch Intern Med 1987;147:1039‐44.CrossRefPubMed
2.
Zurück zum Zitat Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate. Cardiovascular Imaging 2021;14:1221‐31.PubMed Poterucha TJ, Elias P, Bokhari S, Einstein AJ, DeLuca A, Kinkhabwala M. Diagnosing transthyretin cardiac amyloidosis by technetium Tc 99m pyrophosphate. Cardiovascular Imaging 2021;14:1221‐31.PubMed
3.
Zurück zum Zitat Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, et al. Early-phase myocardial uptake intensity of (99m)Tc-HMDP vs (99m)Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol 2018;25:217‐22.CrossRefPubMed Abulizi M, Cottereau AS, Guellich A, Vandeventer S, Galat A, Van Der Gucht A, et al. Early-phase myocardial uptake intensity of (99m)Tc-HMDP vs (99m)Tc-DPD in patients with hereditary transthyretin-related cardiac amyloidosis. J Nucl Cardiol 2018;25:217‐22.CrossRefPubMed
5.
Zurück zum Zitat Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007‐16.CrossRefPubMed Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 2018;379:1007‐16.CrossRefPubMed
7.
Zurück zum Zitat Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195‐201.CrossRefPubMedPubMedCentral Bokhari S, Castano A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 2013;6:195‐201.CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of imaging. Circulation 2021;14:e000029.PubMed Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2—evidence base and standardized methods of imaging. Circulation 2021;14:e000029.PubMed
9.
Zurück zum Zitat Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076‐84.CrossRefPubMed Perugini E, Guidalotti PL, Salvi F, Cooke RM, Pettinato C, Riva L, et al. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy. J Am Coll Cardiol 2005;46:1076‐84.CrossRefPubMed
10.
Zurück zum Zitat Hansen CL. The role of the translation table in cardiac image display. J Nucl Cardiol 2006;13:571‐5.CrossRefPubMed Hansen CL. The role of the translation table in cardiac image display. J Nucl Cardiol 2006;13:571‐5.CrossRefPubMed
11.
Zurück zum Zitat Hansen CL. The “ramp filter” artifact in filtered back projection is due to attenuation not ramp filtering. Nucl Med Commun 2022;43:694‐700.CrossRefPubMed Hansen CL. The “ramp filter” artifact in filtered back projection is due to attenuation not ramp filtering. Nucl Med Commun 2022;43:694‐700.CrossRefPubMed
12.
Zurück zum Zitat Hansen CL. Digital image processing for clinicians, part II: filtering. J Nucl Cardiol 2002;9:429‐37.CrossRefPubMed Hansen CL. Digital image processing for clinicians, part II: filtering. J Nucl Cardiol 2002;9:429‐37.CrossRefPubMed
Metadaten
Titel
Improving evaluation for TTR amyloidosis by interactive filtering of Tc-99 m PYP SPECT images. The role for “clean blood pool” imaging
verfasst von
Christopher L. Hansen, MD, MASNC
Publikationsdatum
12.05.2023
Verlag
Springer International Publishing
Erschienen in
Journal of Nuclear Cardiology / Ausgabe 6/2023
Print ISSN: 1071-3581
Elektronische ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-023-03291-7

Weitere Artikel der Ausgabe 6/2023

Journal of Nuclear Cardiology 6/2023 Zur Ausgabe

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.